Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1229311-61-8

Post Buying Request

1229311-61-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1229311-61-8 Usage

Description

1-(TrifluoroMethyl)cyclopropanecarbaldehyde, also known as TFMCH, is a chemical compound characterized by a cyclopropane ring and a carbonyl group. It is recognized for its strong electron-withdrawing properties due to the trifluoromethyl group, making it a versatile building block in organic synthesis. TFMCH is a highly reactive compound that requires careful handling to prevent the formation of explosive peroxides upon exposure to air and light. It holds significant value in the field of organic chemistry, particularly for its role in introducing the trifluoromethyl group into organic molecules.

Uses

Used in Pharmaceutical Synthesis:
1-(TrifluoroMethyl)cyclopropanecarbaldehyde is used as an intermediate in the synthesis of various pharmaceuticals, leveraging its strong electron-withdrawing properties to facilitate the creation of complex molecular structures.
Used in Agrochemical Production:
TFMCH is utilized as an intermediate in the production of agrochemicals, where its reactivity and electron-withdrawing characteristics contribute to the development of effective compounds for agricultural applications.
Used in Organic Synthesis as a Reagent:
1-(TrifluoroMethyl)cyclopropanecarbaldehyde is used as a reagent in various synthetic processes within the field of organic chemistry. Its ability to introduce the trifluoromethyl group into organic molecules makes it a valuable tool for enhancing the properties of synthesized compounds.
Used in Research and Development:
TFMCH is employed in research and development settings to explore new synthetic pathways and investigate the properties of trifluoromethyl-containing compounds, further expanding the understanding and application of this unique chemical group.

Check Digit Verification of cas no

The CAS Registry Mumber 1229311-61-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,9,3,1 and 1 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1229311-61:
(9*1)+(8*2)+(7*2)+(6*9)+(5*3)+(4*1)+(3*1)+(2*6)+(1*1)=128
128 % 10 = 8
So 1229311-61-8 is a valid CAS Registry Number.

1229311-61-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(trifluoromethyl)cyclopropanecarbaldehyde

1.2 Other means of identification

Product number -
Other names 1-trifluoromethyl-cyclopropanecarbaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1229311-61-8 SDS

1229311-61-8Downstream Products

1229311-61-8Relevant articles and documents

MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR

-

Paragraph 00525; 00526, (2018/04/17)

Compounds of Formula (I), pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.

PYRAZOLE AMIDE DERIVATIVE

-

Page/Page column 93, (2015/09/28)

The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.

MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO

-

Page/Page column 126, (2012/10/18)

The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that are useful as a single agent or in combination with one or more pharmaceutical agents, such as, an inhibitor of DPP-IV, a biguanide, or an alpha-glucosidase inhibitor, in the treatment of, for example, a disorder selected from: a GPR119-receptor-related disorder; a condition ameliorated by increasing a blood incretin level; a metabolic-related disorder; type 2 diabetes; obesity; and complications related thereto.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1229311-61-8